Heat shock protein derivatives for delivery of antigens to antigen presenting cells.
about
Therapeutic physical exercise in neural injury: friend or foe?Choice and Design of Adjuvants for Parenteral and Mucosal VaccinesVaccine therapies in malignant gliomaHyperthermia as an immunotherapy strategy for cancerInduction of tumor-specific immune response by gene transfer of Hsp70-cell-penetrating peptide fusion protein to tumors in mice.The role of TGF-β signaling and apoptosis in innate and adaptive immunity in zebrafish: a systems biology approach.Identification of differentially expressed genes of Trichinella spiralis larvae after exposure to host intestine milieu.Population genetic studies revealed local adaptation in a high gene-flow marine fish, the small yellow croaker (Larimichthys polyactis)Comparative proteomics and expression analysis of five genes in Epicauta chinensis larvae from the first to fifth instar.InCVAX--a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunityHaematoporphyrin based photodynamic therapy combined with hyperthermia provided effective therapeutic vaccine effect against colon cancer growth in miceImplication of Bemisia tabaci heat shock protein 70 in Begomovirus-whitefly interactions.Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccineHsp65-producing Lactococcus lactis prevents experimental autoimmune encephalomyelitis in mice by inducing CD4+LAP+ regulatory T cells.Hsp70 chaperone-based gel composition as a novel immunotherapeutic anti-tumor tool.Heat-shock protein vaccines as active immunotherapy against human gliomas.Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients.The specialized roles of immature and mature dendritic cells in antigen cross-presentation.Vaccine therapies for patients with glioblastoma.Proteomic analysis of potential immunoreactive proteins from muscle larvae and adult worms of Trichinella spiralis in experimentally infected pigs.Tumor Vaccines for Malignant Gliomas.Modulatory role of calreticulin as chaperokine for dendritic cell-based immunotherapy.Hsp65-Producing Lactococcus lactis Prevents Inflammatory Intestinal Disease in Mice by IL-10- and TLR2-Dependent Pathways.Differential impact of treadmill training on stroke-induced neurological disorders.Spectroscopic and thermodynamic properties of recombinant heat shock protein A6 from Camelus dromedarius.Functional annotation of structural ncRNAs within enhancer RNAs in the human genome: implications for human disease.Designing and modeling of complex DNA vaccine based on tropomyosin protein of Boophilus genus tick.Current challenges for cancer vaccine adjuvant development.Immune-mediated disorders among women carriers of fragile X premutation alleles.Immune mediated disorders in women with a fragile X expansion and FXTAS.Recombinant Fusion Protein Joining E Protein Domain III of Tick-Borne Encephalitis Virus and HSP70 of as an Antigen for the TI-Complexes
P2860
Q26772862-93599DD6-1F7E-4BA1-B405-1792FCD0E5FCQ26783488-5371E243-A51E-4763-9BC0-6F889652A852Q26829328-1022828F-1F75-4EC7-BF22-596311C20CEFQ33686985-CB20BA3A-26CC-4856-97B4-09B725C8002BQ33730763-B368263C-BBCA-4460-9FD1-5542A1162ABDQ34474384-D6CB554A-D191-4FB3-8CCC-41BDC7333F31Q34807713-923F46FC-2B67-462B-A3E2-66B8B162073EQ35070999-A9F02534-7BD6-4050-98D2-3024E59A7227Q35107720-A2858D0F-A46D-4427-94E1-621CB60A3699Q35108944-CFD8A069-E074-46E8-A930-19D7B263000FQ36302213-0CB3766E-3172-467D-AFC3-7AB2F215AE92Q36414550-B0F58421-AC29-4770-B335-9CD76959816FQ36702887-A0FA9B06-0106-4C07-8563-954720B21364Q36758537-C21BDE17-AAD7-4DCA-A45B-FDC4D884937BQ36780372-51ED3A34-3D21-444D-BD72-56C526D7C727Q37331708-23972820-DE79-4113-89DC-6C85B03E2CB2Q37367956-7D772FA6-1961-4496-87E7-DB1ABC6F18D3Q37997315-E0D19C37-CAAF-45EF-AD7B-33CF08088CF3Q38243975-F5F96934-382F-4B8F-8B43-C84430CE7C8AQ38463378-A05CAE12-DCA6-4E84-AEFB-7B3958676244Q39228039-2830F11F-C61C-4FC8-8122-71231DDA8C41Q39531728-CDD3488E-3054-4915-9B0B-58282E092682Q41867495-F6E66988-19B5-4C0A-AA50-6B0F35AC8699Q42689926-2E2C6C44-BBDA-40BC-A05B-CE635E265058Q45778031-46DD3CE9-BBFD-47AF-B87D-F79B5915BB1EQ46261346-237347D5-311F-4B84-ADF0-98A48688020FQ46831913-B3E5456F-43A6-4B90-B9B5-7264127743BBQ48160317-AEDCB6FE-E4D7-4351-AA2C-25EE3CCAB251Q55637365-8DBFB875-715E-41C6-8040-9BFC464B14B9Q55665860-94AEF3CC-79F0-4BE3-8F22-CEE064AF8B2AQ58702522-D35ABD8D-D13B-4215-BB1F-47EA5F5B58BC
P2860
Heat shock protein derivatives for delivery of antigens to antigen presenting cells.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Heat shock protein derivatives for delivery of antigens to antigen presenting cells.
@ast
Heat shock protein derivatives for delivery of antigens to antigen presenting cells.
@en
Heat shock protein derivatives for delivery of antigens to antigen presenting cells.
@nl
type
label
Heat shock protein derivatives for delivery of antigens to antigen presenting cells.
@ast
Heat shock protein derivatives for delivery of antigens to antigen presenting cells.
@en
Heat shock protein derivatives for delivery of antigens to antigen presenting cells.
@nl
prefLabel
Heat shock protein derivatives for delivery of antigens to antigen presenting cells.
@ast
Heat shock protein derivatives for delivery of antigens to antigen presenting cells.
@en
Heat shock protein derivatives for delivery of antigens to antigen presenting cells.
@nl
P2093
P1476
Heat shock protein derivatives for delivery of antigens to antigen presenting cells.
@en
P2093
Makiya Nishikawa
Seiji Takemoto
Yoshinobu Takakura
P356
10.1016/J.IJPHARM.2007.09.030
P407
P577
2007-09-29T00:00:00Z